The final determination also adds coverage for FDA-approved tests in stage III patients, and for repeat testing if patients receive a new primary diagnosis.

The decision, which the company said was made for business and financial reasons, raises questions about the viability of such tests in the face of reimbursement uncertainly.

These lobbying efforts aim to shore up willingness among legislators to step in and halt implementation of the NCD if certain provisions remain in the final version.

An impetus for the review included the fact that companies are advertising and promoting liquid biopsy in areas where the technology has not yet proven its clinical utility.

As genomics increasingly becomes a part of healthcare, more diverse datasets will be needed to avoid biases in algorithms used to analyze data and make diagnoses.

Chugai, a member of the Roche Group, has already filed for regulatory approval of FoundationOne CDx with Japan's Ministry of Health, Labor, and Welfare.

The companies also agreed to establish a working group to explore the development of standard formulas and definitions for the validation of genomic profiling assays.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.

Sponsored by

Machine learning is a field of computer science that gives computers the ability to learn without being explicitly programmed. This webinar explores the basics of machine learning, focusing on the industry standard CRISP-DM (Cross Industry Standard Process for Data Mining), and how to apply the method to a molecular diagnostic technique such as PCR. The webinar also discusses the implications of current PCR analysis software and the lack of artificial intelligence. Lastly - a novel and improved way of analyzing PCR results is introduced.

This application note demonstrates that:

• The new Applied Biosystems SeqStudio Genetic Analyzer generates high-quality data from multiplex ligation–dependent probe amplification (MLPA) assays developed by MRC-Holland.

• The SeqStudio Genetic Analyzer provides fast and efficient results; each run cycle accommodates 4 MLPA reaction samples and can be completed within 45 min.